CIK 0001649989 · Non-accelerated filer<br>Smaller reporting company
Outlook Therapeutics, Inc.
Sign in to watch- Ticker
- OTLK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383982704
- Phone
- 6096193990
- Business address
- 111 S. WOOD AVENUE, UNIT #100, ISELIN, NJ, 08830
- Former names
- Oncobiologics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-10-05 | HILZINGER KURT J Director | Purchase | +15,662 | $1.23 | $19K | 473,117 |
| 2022-10-04 | HILZINGER KURT J Director | Purchase | +95,541 | $1.29 | $123K | 457,455 |
| 2022-10-03 | HILZINGER KURT J Director | Purchase | +41,798 | $1.25 | $52K | 361,914 |
| 2022-09-30 | HILZINGER KURT J Director | Purchase | +33,199 | $1.26 | $42K | 320,116 |
| 2022-09-29 | HILZINGER KURT J Director | Purchase | +13,800 | $1.19 | $16K | 286,917 |
| 2022-08-11 | Haller Julia A Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-21 | Dagnon Terry Chief Operating Officer | Purchase | +10,000 | $1.05 | $11K | 1,173,058 |
| 2022-06-21 | TRENARY C RUSSELL III CEO and President | Purchase | +19,925 | $1.06 | $21K | 54,925 |
| 2022-04-21 | Sukhtian Ghiath M. Director | Other acquisition | +27,982,529 | 55,816,786 | ||
| 2022-04-21 | Sukhtian Faisal Ghiath Director | Other acquisition | +27,982,529 | 55,816,786 | ||
| 2022-04-21 | BioLexis Pte Ltd. 10% owner | Other disposition | −27,982,529 | 22,982,529 | ||
| 2022-03-31 | Evanson Jeff Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-31 | Dagnon Terry Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-03-31 | TRENARY C RUSSELL III CEO and President | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2022-03-23 | Gangolli Julian S Director | Grant or award · Stock Option (Right to Buy) | +21,878 | 21,878 | ||
| 2022-03-23 | HILZINGER KURT J Director | Grant or award · Stock Option (Right to Buy) | +21,878 | 21,878 | ||
| 2022-03-23 | Sukhtian Faisal Ghiath Director | Grant or award · Stock Option (Right to Buy) | +21,878 | 21,878 | ||
| 2022-03-23 | Haddadin Yezan Munther Director | Grant or award · Stock Option (Right to Buy) | +21,878 | 21,878 | ||
| 2022-03-23 | Auffarth Gerd Director | Grant or award · Stock Option (Right to Buy) | +21,878 | 21,878 | ||
| 2022-03-23 | Huang Andong Director | Grant or award · Stock Option (Right to Buy) | +21,878 | 21,878 |
Page 7 of 8 · 142 trades